[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"noninfectious-posterior-uveitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:noninfectious-posterior-uveitis":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100625500","frequency-and-intensity-of-inflammatory-relapses-in-patients-with-non-infectious-posterior-uveitis-treated-with-a-fluocinolone-acetonide-implant-100625500",false,"NCT07423442","Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant","Frequency and Intensity of REcurrences in Non-infectious Posterior Uveitis Treated With Fluocinolone Acetonide Implant (FACi): a Multicenter Retrospective Real-world Study","FIRE","Inclusion Criteria:\n\n* Adult patients aged 18 years or older\n* Diagnosis of non-infectious uveitis with posterior segment involvement\n* Presence of uveitic macular edema or persistent posterior segment inflammation\n* Treatment with a fluocinolone acetonide intravitreal implant prior to January 2024\n\nExclusion Criteria:\n\n* Infectious uveitis\n* Refusal to participate or documented opposition to the study\n* Follow-up duration shorter than 12 months after implantation","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","Non-infectious posterior uveitis is a chronic inflammatory eye disease that can lead to irreversible retinal damage and visual impairment due to repeated inflammatory relapses.\n\nThe fluocinolone acetonide intravitreal implant is approved for the prevention of inflammatory relapses in this condition, but data from real-world clinical practice remain limited, particularly regarding the intensity of relapses over time.\n\nThis multicenter retrospective observational study aims to evaluate the frequency and intensity of inflammatory recurrences in adult patients with non-infectious posterior uveitis treated with a fluocinolone acetonide implant. Clinical and imaging data routinely collected during follow-up will be analyzed over a three-year period to better characterize long-term outcomes, treatment burden, and safety in real-life conditions.",[25,26,27],"Noninfectious Posterior Uveitis","Uveitis, Posterior","Uveitic Macular Edema","NOT_YET_RECRUITING","2026-06-23",{"date":31,"type":32},"2026-06-24","ACTUAL",{"date":34,"type":21},"2026-06",{"date":36,"type":21},"2027-01",{"name":38,"class":39},"Nantes University Hospital","OTHER"]